UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 11, 2014

 

 

PSIVIDA CORP.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   000-51122   26-2774444

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

480 Pleasant Street

Watertown, MA 02472

(Address of Principal Executive Offices) (Zip Code)

(617) 926-5000

(Registrant’s Telephone Number, Including Area Code)

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders of pSivida Corp. (the “Company”) was held on December 11, 2014. The stockholders elected each of the Company’s nominees for director, approved the stock option grant to the Company’s Chief Executive Officer, approved the stock option grants to the Company’s non-executive directors, ratified the issuance of common stock to funds affiliated with RA Capital in March 2014 and under the Company’s ATM facility in December 2013, approved, on an advisory basis, the Company’s 2014 executive compensation and ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2015. The proposals below are described in detail in the Company’s definitive proxy statement filed with the SEC on October 24, 2014.

The results are as follows:

 

1. Election of Directors.

 

DIRECTOR NOMINEE    FOR      WITHHELD      NON VOTE  

David J. Mazzo

     8,546,783         467,113         10,958,201   

Paul Ashton

     8,450,417         563,479         10,958,201   

Douglas Godshall

     8,549,121         464,775         10,958,201   

James Barry

     8,548,533         465,363         10,958,201   

Michael Rogers

     8,549,533         464,363         10,958,201   

Peter G. Savas

     8,546,446         467,450         10,958,201   

 

2. Approval of stock option grant to the Company’s Chief Executive Officer.

 

FOR

     7,341,829   

AGAINST

     1,473,255   

ABSTAIN

     198,812   

NON VOTES

     10,958,201   

 

3. Approval of stock option grant to the following non-executive directors.

 

DIRECTOR    FOR      AGAINST      ABSTAIN      NON VOTES  

James Barry

     7,451,182         1,413,569         149,145         10,958,201   

Douglas Godshall

     7,256,582         1,608,169         149,145         10,958,201   

Michael Rogers

     7,253,582         1,611,169         149,145         10,958,201   

Peter G. Savas

     7,251,482         1,613,269         149,145         10,958,201   

David J Mazzo

     7,332,822         1,532,869         148,205         10,958,201   


4. For purposes of ASX Listing Rule 7.4

 

  a. Ratification of the issuance and sale of 1,700,000 shares of common stock in a March 2014 registered direct offering

 

FOR

     8,269,619   

AGAINST

     673,949   

ABSTAIN

     70,328   

NON VOTES

     10,958,201   

 

  b. Ratification of the issuance and sale of 381,562 shares of common stock under the Company’s ATM in December 2013

 

FOR

     8,277,306   

AGAINST

     659,789   

ABSTAIN

     76,801   

NON VOTES

     10,958,201   

 

5. Advisory vote on the Company’s 2014 executive compensation

 

FOR

     7,874,575   

AGAINST

     844,203   

ABSTAIN

     295,118   

NON VOTES

     10,958,201   

 

6. Ratification of the appointment of Deloitte & Touche LLP.

 

FOR

     17,430,482   

AGAINST

     1,945,499   

ABSTAIN

     596,116   


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

PSIVIDA CORP.

Date: December 15, 2014     By:  

/s/ Lori Freedman

      Lori Freedman, Vice President, Corporate Affairs,
      General Counsel and Secretary